Stockscreener 앱 받기
7.14
2.72%
-0.20
시간 외 거래:
7.28
0.14
+1.96%
전일 마감가:
$7.34
열려 있는:
$7.33
하루 거래량:
1.45M
Relative Volume:
0.84
시가총액:
$1.23B
수익:
$25.55M
순이익/손실:
$-341.97M
주가수익비율:
-2.55
EPS:
-2.8
순현금흐름:
$-304.44M
1주 성능:
+4.08%
1개월 성능:
+36.78%
6개월 성능:
+114.41%
1년 성능:
+26.71%
1일 변동 폭
$7.125
$7.4199
1주일 범위
$6.965
$7.64
52주 변동 폭
$1.775
$7.64
릴레이 테라퓨틱스 Stock (RLAY) Company Profile
명칭
Relay Therapeutics Inc
전화
617-370-8837
주소
60 HAMPSHIRE STREET, CAMBRIDGE
RLAY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
7.14 | 1.27B | 25.55M | -341.97M | -304.44M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
릴레이 테라퓨틱스 Stock (RLAY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 재개 | Guggenheim | Buy |
| 2025-04-17 | 개시 | Wells Fargo | Equal Weight |
| 2024-09-10 | 재개 | Goldman | Buy |
| 2024-09-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-09-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-05-10 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-04-20 | 업그레이드 | Jefferies | Underperform → Hold |
| 2023-04-19 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | 개시 | Raymond James | Outperform |
| 2023-02-03 | 개시 | Oppenheimer | Outperform |
| 2022-09-30 | 개시 | Barclays | Equal Weight |
| 2022-09-02 | 개시 | Stifel | Buy |
| 2022-06-06 | 개시 | Jefferies | Underperform |
| 2022-02-01 | 개시 | Berenberg | Buy |
| 2021-07-21 | 개시 | BofA Securities | Buy |
| 2020-12-15 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-08 | 개시 | JMP Securities | Mkt Outperform |
| 2020-11-05 | 개시 | H.C. Wainwright | Buy |
| 2020-08-10 | 개시 | Cowen | Outperform |
| 2020-08-10 | 개시 | Goldman | Buy |
| 2020-08-10 | 개시 | Guggenheim | Buy |
| 2020-08-10 | 개시 | JP Morgan | Neutral |
모두보기
릴레이 테라퓨틱스 주식(RLAY)의 최신 뉴스
Regression analysis insights on Relay Therapeutics Inc. performanceShare Buyback & Consistent Return Strategy Ideas - newser.com
What machine learning models say about Relay Therapeutics Inc.July 2025 Summary & Daily Price Action Insights - newser.com
Has Relay Therapeutics Inc. found a price floorJuly 2025 Macro Moves & Smart Allocation Stock Reports - newser.com
Why hedge funds are buying Relay Therapeutics Inc. stockJuly 2025 Selloffs & Verified Trade Idea Suggestions - newser.com
Does Relay Therapeutics Inc. show high probability of reboundLayoff News & Stock Timing and Entry Methods - newser.com
Using Ichimoku Cloud for Relay Therapeutics Inc. technicalsPortfolio Return Summary & Precise Entry and Exit Recommendations - newser.com
Relay Therapeutics Inc.’s volatility index tracking explained2025 Breakouts & Breakdowns & Consistent Income Trade Ideas - newser.com
Backtesting results for Relay Therapeutics Inc. trading strategiesGap Down & Weekly Market Pulse Alerts - newser.com
How to use a screener to detect Relay Therapeutics Inc. breakouts2025 Short Interest & Stepwise Trade Signal Guides - newser.com
Key metrics from Relay Therapeutics Inc.’s quarterly dataGap Up & Verified Entry Point Signals - newser.com
Analyzing recovery setups for Relay Therapeutics Inc. investorsJuly 2025 Fed Impact & High Yield Equity Trading Tips - newser.com
Building trade automation scripts for Relay Therapeutics Inc.Bond Market & Technical Pattern Alert System - newser.com
Is Relay Therapeutics Inc. stock a top momentum play2025 Price Momentum & Short-Term Trading Alerts - newser.com
Relay Therapeutics (NASDAQ:RLAY) Insider Donald Bergstrom Sells 30,897 Shares - MarketBeat
Peter Rahmer Sells 21,394 Shares of Relay Therapeutics (NASDAQ:RLAY) Stock - MarketBeat
Relay Therapeutics (NASDAQ:RLAY) Insider Peter Rahmer Sells 19,135 Shares - MarketBeat
Insider Selling: Relay Therapeutics (NASDAQ:RLAY) CFO Sells 21,664 Shares of Stock - MarketBeat
Why retail investors favor Relay Therapeutics Inc. stockJuly 2025 Review & High Conviction Investment Ideas - newser.com
How to forecast Relay Therapeutics Inc. trends using time seriesProduct Launch & AI Powered Market Entry Ideas - newser.com
What drives Relay Therapeutics Inc stock priceValue Traps to Avoid & Join 100,000+ Investors Already Learning - earlytimes.in
Relay Therapeutics Reaches New 52-Week High of $7.64 - Markets Mojo
Relay Therapeutics president sells $225k in stock By Investing.com - Investing.com Canada
Relay Therapeutics president sells $225k in stock - Investing.com
Relay Therapeutics Executives and Director Sell Shares for Tax Obligations - TradingView
Relay Therapeutics Executives Sell Shares for Tax Obligations - TradingView
Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025 - The Manila Times
RLAY insider sells shares; RSU vesting drives tax withholding - Stock Titan
Relay Therapeutics CFO sale: 21,664 shares at $7.29 - Stock Titan
Wall Street Analysts Think Relay Therapeutics (RLAY) Could Surge 86.05%: Read This Before Placing a Bet - sharewise.com
Relay Therapeutics (RLAY) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Is Relay Therapeutics Inc. stock positioned for long term growthJuly 2025 Setups & Verified Technical Signals - newser.com
Published on: 2025-10-30 02:36:30 - newser.com
Relay Therapeutics (NASDAQ:RLAY) Sets New 12-Month HighWhat's Next? - MarketBeat
Relay Therapeutics Hits New 52-Week High of $7.50, Marking Major Milestone - Markets Mojo
릴레이 테라퓨틱스 (RLAY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):